Progress on the multifunctional mesoporous silica-based nanotheranostics

Wuji Cailiao Xuebao/Journal of Inorganic Materials

Volumn 28, Issue 1, 2013, Pages 1-11

  Shi, Jian Lin ^a   Chen, Yu ^a   Chen, Hang Rong ^a  

^a SHANGHAI INSTITUTE OF CERAMICS   (China)

Author keywords

Biomaterials; Cancer; Mesoporous; Molecular imaging; Nanomaterials; Nanotheranostics; Review

Indexed keywords

BIOLOGICAL EFFECTS; BIONANOTECHNOLOGY; BROAD APPLICATION; CANCER; CLINICAL PRACTICES; CONTRAST AGENT; DESIGN STRATEGIES; DEVELOPMENT TRENDS; EARLY DIAGNOSIS; FLUORESCENT IMAGING; HUMAN BEING; IMAGING MODALITY; MESOPOROUS; MESOPOROUS SILICA NANOPARTICLES; NANOTHERANOSTICS; RECENT RESEARCHES; SURGICAL THERAPY; SYSTEMATIC INVESTIGATIONS; TARGETED DRUG DELIVERY; VARIOUS FUNCTIONS;

BIOLOGICAL MATERIALS; BIOMATERIALS; CHEMOTHERAPY; DIAGNOSIS; DISEASE CONTROL; DISEASES; DRUG DELIVERY; GENE THERAPY; IMPLANTS (SURGICAL); MAGNETIC RESONANCE IMAGING; MOLECULAR IMAGING; NANOSTRUCTURED MATERIALS; PHOTODYNAMIC THERAPY; REVIEWS; SURGERY; TISSUE ENGINEERING;

MESOPOROUS MATERIALS;

EID: 84874475149     PISSN: 1000324X     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1077.2012.12082     Document Type: Article

References (50)

1. Lammers T, Aime S, Hennink W E, et al. Theranostic nanomedicine. Accounts Chem. Res., 2011, 44(10): 1029-1038.
2. Kievit F M, Zhang M Q. Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers. Adv. Mater., 2011, 23(36): H217-H247.
3. Lammers T, Kiessling F, Hennink W E, et al. Nanotheranostics and image-guided drug delivery: current concepts and future directions. Mol. Pharm., 2010, 7(6): 1899-1912.
4. Slowing II, Vivero-Escoto J L, Wu C W, et al. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv. Drug Deliv. Rev., 2008, 60(11): 1278-1288.
5. Vallet-Regi M, Balas F, Arcos D. Mesoporous materials for drug delivery. Angew. Chem. Int. Ed., 2007, 46(40): 7548-7558.
6. Liong M, Angelos S, Choi E, et al. Mesostructured multifunctional nanoparticles for imaging and drug delivery. J. Mater. Chem., 2009, 19(35): 6251-6257.
7. Wang S B. Ordered mesoporous materials for drug delivery. Micro. Meso. Mater., 2009, 117(1/2): 1-9.
8. Kresge C T, Leonowicz M E, Roth W J, et al. Ordered mesoporous molecular-sieves synthesized by a liquid-crystal template mechanism. Nature, 1992, 359(6397): 710-712.
9. Piao Y, Burns A, Kim J, et al. Designed fabrication of silica-based nanostructured particle systems for nanomedicine applications. Adv. Funct. Mater., 2008, 18(23): 3745-3758.
10. He Q J, Shi J L. Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility. J. Mater. Chem., 2011, 21(16): 5845-5855.
11. Vallet-Regi M, Ramila A, del Real R P, et al. A new property of MCM-41: drug delivery system. Chem. Mater., 2001, 13(2): 308-311.
12. Coti K K, Belowich M E, Liong M, et al. Mechanised nanoparticles for drug delivery. Nanoscale, 2009, 1(1): 16-39.
13. Lu J, Liong M, Li Z X, et al. Biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small, 2010, 6(16): 1794-1805.
14. Li L L, Tang F Q, Liu H Y, et al. In vivo delivery of silica nanorattle encapsulated docetaxel for liver cancer therapy with low toxicity and high efficacy. ACS Nano, 2010, 4(11): 6874-6882.
15. He Q J, Zhang J M, Shi J L, et al. The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses. Biomaterials, 2010, 31(6): 1085-1092.
16. Huang X L, Li L L, Liu T L, et al. The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo. ACS Nano, 2011, 5(7): 5390-5399.
17. Chen Y, Chen H R, Zeng D P, et al. Core/shell structured hollow mesoporous nanocapsules: a potential platform for simultaneous cell imaging and anticancer drug delivery. ACS Nano, 2010, 4(10): 6001-6013.
18. Chen Y, Chen H R, Sun Y, et al. Multifunctional mesoporous composite nanocapsules for highly efficient MRI-guided high-intensity focused ultrasound cancer surgery. Angew. Chem. Int. Ed., 2011, 50(52): 12505-12509.
19. Chen Y, Chen H R, Zhang S J, et al. Multifunctional mesoporous nanoellipsoids for biological bimodal imaging and magnetically targeted delivery of anticancer drugs. Adv. Funct. Mater., 2011, 21(2): 270-278.
20. Lee C H, Cheng S H, Wang Y J, et al. Near-infrared mesoporous silica nanoparticles for optical imaging: characterization and in vivo biodistribution. Adv. Funct. Mater., 2009, 19(2): 215-222.
21. Zhao W R, Gu J L, Zhang L X, et al. Fabrication of uniform magnetic nanocomposite spheres with a magnetic core/mesoporous silica shell structure. J. Am. Chem. Soc., 2005, 127(25): 8916-8917.
22. 2 shell for removal of microcystins. J. Am. Chem. Soc., 2008, 130(1): 28-29.
23. Kim J, Lee J E, Lee J, et al. Magnetic fluorescent delivery vehicle using uniform mesoporous silica spheres embedded with monodisperse magnetic and semiconductor nanocrystals. J. Am. Chem. Soc., 2006, 128(3): 688-689.
24. Kim J, Kim H S, Lee N, et al. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angew. Chem. Int. Ed., 2008, 47(44): 8438-8441.
25. Lee J E, Lee N, Kim H, et al. Uniform mesoporous dye-doped silica nanoparticles decorated with multiple magnetite nanocrystals for simultaneous enhanced magnetic resonance imaging, fluorescence imaging, and drug delivery. J. Am. Chem. Soc., 2010, 132(2): 552-557.
26. 4 nanoparticles- capped mesoporous silica. Biomaterials, 2011, 32(7): 1932-1942.
27. Viswanathan S, Kovacs Z, Green K N, et al. Alternatives to gadolinium-based metal chelates for magnetic resonance imaging. Chem. Rev., 2010, 110(5): 2960-3018.
28. Terreno E, Castelli D D, Viale A, et al. Challenges for molecular magnetic resonance imaging. Chem. Rev., 2010, 110(5): 3019-3042.
29. Taylor K M L, Kim J S, Rieter W J, et al. Mesoporous silica nanospheres as highly efficient MRI contrast agents. J. Am. Chem. Soc., 2008, 130(7): 2154-2155.
30. Hsiao J K, Tsai C P, Chung T H, et al., Mesoporous silica nanoparticles as a delivery system of gadolinium for effective human stem cell tracking. Small, 2008, 4 (9): 1445-1452.
31. Penfield J G, Reilly R F. What nephrologists need to know about gadolinium. Nat. Clin. Pract. Nephrol., 2007, 3 (12): 654-668.
32. Tromsdorf U I, Bruns O T, Salmen S C, et al. A highly effective, nontoxic T-1 MR contrast agent based on ultrasmall PEGylated iron oxide nanoparticles. Nano Lett., 2009, 9 (12): 4434-4440.
33. Perez-Rodriguez J, Lai S, Ehst B D, et al. Nephrogenic systemic fibrosis: incidence, associations, and effect of risk factor assessment-report of 33 cases. Radiology, 2009, 250(2): 371-377.
34. Na H B, Lee J H, An K J, et al. Development of a T-1 contrast agent for magnetic resonance imaging using MnO nanoparticles. Angew. Chem. Int. Ed., 2007, 46(28): 5397-5401.
35. 2 core/shell nanocomposites. ACS Nano, 2011, 5 (5): 4177-4187.
36. Schladt T D, Shukoor M I, Schneider K, et al. Au@MnO nanoflowers: hybrid nanocomposites for selective dual functionalization and imaging. Angew. Chem. Int. Ed., 2010, 49(23): 3976-3980.
37. Kim T, Momin E, Choi J, et al. Mesoporous silica-coated hollow manganese oxide nanoparticles as positive T(1) contrast agents for labeling and MRI tracking of adipose-derived mesenchyrnal stem cells. J. Am. Chem. Soc., 2011, 133(9): 2955-2961.
38. Chen Y, Chen H, Zhang S, et al. Structure-property relationships in manganese oxide-mesoporous silica nanoparticles used for T1-weighted MRI and simultaneous anti-cancer drug delivery. Biomaterials, 2012, 33 (7): 2388-2398.
39. Pan J, Wan D, Gong J L. PEGylated liposome coated QDs/mesoporous silica core-shell nanoparticles for molecular imaging. Chem. Commun., 2011, 47(12): 3442-3444.
40. Qian H S, Guo H C, Ho P C L, et al. Mesoporous-silica-coated up-conversion fluorescent nanoparticles for photodynamic therapy. Small, 2009, 5(20): 2285-2290.
41. He Q J, Shi J L, Cui X Z, et al. Synthesis of oxygen-deficient luminescent mesoporous silica nanoparticles for synchronous drug delivery and imaging. Chem. Commun., 2011, 47(28): 7947-7949.
42. Feng J, Song S Y, Deng R P, et al. Novel multifunctional nanocomposites: magnetic mesoporous silica nanospheres covalently bonded with near-infrared luminescent lanthanide complexes. Langmuir, 2010, 26(5): 3596-3600.
43. Liu J, Bu W, Zhang S, et al. Controlled synthesis of uniform and monodisperse upconversion core/mesoporous silica shell nanocomposites for bimodal imaging. Chem. Eur. J., 2012, 18(8): 2335-2341.
44. Ma M, Chen H, Chen Y, et al. Au capped magnetic core/mesoporous silica shell nanoparticles for combined photothermo-/chemo-therapy and multimodal imaging. Biomaterials, 2012, 33(3): 989-998.
45. Chen Y, Gao Y, Chen H, et al. Engineering inorganic nanoemulsions/nanoliposomes by fluoride-silica chemistry for efficient delivery/Co-delivery of hydrophobic agents. Adv. Funct. Mater., 2012, 22(8): 1586-1597.
46. Wang X, Chen H, Chen Y, et al. Perfluorohexane-encapsulated mesoporous silica nanocapsules as enhancement agents for highly efficient high intensity focused ultrasound (HIFU). Adv. Mater., 2012, 24(6): 785-791.
47. Takegami K, Kaneko Y, Watanabe T, et al. Heating and coagulation volume obtained with high-intensity focused ultrasound therapy: comparison of perflutren protein-type A microspheres and MRX-133 in rabbits. Radiology, 2005, 237(1): 132-136.
48. Kennedy J E, Haar G R, Cranston D. High intensity focused ultrasound: surgery of the future? Br. J. Radiol., 2003, 76(909): 590-599.
49. Bailey M R, Khokhlova V A, Sapozhnikov O A, et al. Physical mechanisms of the therapeutic effect of ultrasound - a review. Acoust. Phys., 2003, 49 (4): 369-388.
50. Hynynen K. MRI-guided focused ultrasound treatments. Ultrasonics, 2010, 50 (2): 221-229.